DiaMedica Therapeutics (DMAC) Financials: Revenue & Earnings

DMAC price $9.66 +0.97 +11.16%

Ticker
DMAC
Price
$9.66
Change
+0.97 +11.16%
Market cap ?
$520.93M
P/E ?
-12.11
Dividend yield ?
0.00%
Beta ?
0.91
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
32
Value
35
Quality
47
Growth
15

Stocklytics score rationale: value 35, quality 47, growth 15.

Financials

2016201720182019202020212022202320242025
005000000000000

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, a recombinant human tissue kallikrein-1 protein, is currently undergoing a Phase 2 REDUX trial to assess its efficacy in treating moderate to severe chronic kidney disease linked to Type 1 or Type 2 diabetes…

Fair value

DMAC fair value Not meaningful. Price $9.66.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare DMAC

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.20—13.50M
2026-08-10-0.19-0.20—13.50M
2026-05-06-0.19-0.17—13.50M
2026-03-30-0.17-0.17——
2025-11-12-0.17-0.15——
2025-08-12-0.18-0.18——
2025-05-13-0.18-0.18——
2025-03-17-0.18-0.17——
2024-11-13-0.15-0.15——
2024-08-07-0.13-0.16——
2024-05-08-0.14-0.16——
2024-03-19-0.14-0.1430.84M—
2023-11-13-0.12-0.14——
2023-08-14-0.16-0.22——
2023-05-15-0.20-0.16——
2023-03-28-0.14-0.14——
2022-11-09-0.12-0.1376.00K—
2022-08-10-0.13-0.1613.00K—
2022-05-04-0.13-0.20——
2022-03-14-0.10-0.16——
2021-11-10-0.18-0.23——
2021-08-11-0.17-0.19——
2021-05-05-0.19-0.23——
2021-03-10-0.23-0.18——
2020-11-04-0.19———
2020-08-11-0.17-0.15——
2020-05-13-0.19-0.28——
2020-03-23-0.21-0.25——
2019-11-13-0.20-0.19——
2019-08-13-0.21-0.28——
2019-05-13-0.27-0.22——
2019-03-19-0.23-0.20-3.66K—
2018-12-10-0.07—503.66K—
2018-11-19-0.07———
2018-04-30-0.16———
2018-03-31-0.09———
2017-11-27-0.15———
2017-08-29-0.18———
2017-05-30-0.24———
2017-04-27-0.09———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-10Pauls Dietrich JohnBuy60.20K——
2026-01-02Parsons James T.Buy10.10K$8.4285.00K
2026-01-02Giuffre Randall MichaelBuy6.17K$8.4251.99K
2026-01-02Semba Charles PaulingBuy3.35K$8.4228.25K
2025-11-25STAHLBERG JANBuy73.10K$8.57626.82K
2025-11-24STAHLBERG JANBuy40.25K$7.89317.72K
2025-11-21STAHLBERG JANBuy208.87K$7.411.55M
2025-11-21Parsons James T.Buy12.00K$2.2026.40K
2025-11-21Parsons James T.Sell12.00K$2.2026.40K
2025-11-20STAHLBERG JANBuy128.43K$7.41951.21K
2025-11-19STAHLBERG JANBuy240.35K$7.211.73M
2025-11-18STAHLBERG JANBuy182.88K$6.751.23M
2025-11-17STAHLBERG JANBuy187.39K$6.521.22M
2025-08-27STAHLBERG JANBuy50.77K$6.00304.63K
2025-08-26STAHLBERG JANBuy59.65K$6.00357.89K
2025-08-25STAHLBERG JANBuy338.26K$6.002.03M
2025-08-22STAHLBERG JANBuy59.79K$5.96356.58K
2025-08-21STAHLBERG JANBuy48.17K$5.96287.03K
2025-08-20STAHLBERG JANBuy71.11K$5.86416.50K
2025-08-15STAHLBERG JANBuy8.23K$6.0049.40K
2025-08-14STAHLBERG JANBuy70.41K$5.99421.92K
2025-08-13STAHLBERG JANBuy293.60K$5.911.73M
2025-08-11Krop JulieBuy450.00K$4.582.06M
2025-08-11Krop JulieOther0——
2025-07-23STAHLBERG JANBuy1.54M$3.505.40M
2025-07-23Von Koch ThomasBuy2.86M$3.5010.00M
2025-07-23JACINTO RICHARD IIBuy400.00K$3.501.40M
2025-06-01Wambeke David J.Buy250.00K$4.111.03M
2025-06-01Semba Charles PaulingBuy32.16K$4.11132.19K
2025-06-01Pauls Dietrich JohnBuy600.00K$4.112.47M
2025-06-01Parsons James T.Buy40.74K$4.11167.44K
2025-06-01Lewis TanyaBuy32.16K$4.11132.19K
2025-06-01Kuntz RichardBuy32.16K$4.11132.19K
2025-06-01Kellen ScottBuy225.00K$4.11924.75K
2025-06-01Giuffre Randall MichaelBuy32.16K$4.11132.19K
2025-04-07Pilnik Richard D.Buy24.00K$2.1150.64K
2025-04-07Pilnik Richard D.Sell24.00K$2.1150.64K
2025-02-20O'Connor Daniel J.Buy64.24K$6.61424.64K
2025-02-20O'Connor Daniel J.Other0——
2025-02-13Giuffre Randall MichaelBuy5.00K$3.6518.25K
2025-02-13Giuffre Randall MichaelBuy12.00K$2.1125.32K
2025-02-13Giuffre Randall MichaelSell5.00K$3.6518.25K
2025-02-13Giuffre Randall MichaelSell12.00K$2.1125.32K
2025-01-02Parsons James T.Buy15.92K$5.3485.00K
2025-01-02Parsons James T.Buy4.29K$5.5123.62K
2025-01-02Giuffre Randall MichaelBuy10.86K$5.3458.00K
2025-01-02Kuntz RichardBuy9.93K$5.3453.00K
2025-01-02Pilnik Richard D.Buy10.39K$5.3455.50K
2025-01-02Semba Charles PaulingBuy5.29K$5.3428.25K
2024-06-28Von Koch ThomasBuy1.20M$2.503.00M
2024-06-28STAHLBERG JANBuy1.20M$2.503.00M
2024-06-01Wambeke David J.Buy130.00K$2.90377.00K
2024-06-01Kellen ScottBuy130.00K$2.90377.00K
2024-06-01Cundari Dominic RBuy15.00K$2.9043.50K
2024-06-01Pauls Dietrich JohnBuy300.00K$2.90870.00K
2024-06-01Semba Charles PaulingBuy28.47K$2.9082.57K
2024-06-01Pilnik Richard D.Buy36.06K$2.90104.59K
2024-06-01Parsons James T.Buy28.47K$2.9082.57K
2024-06-01Lewis TanyaBuy28.47K$2.9082.57K
2024-06-01Kuntz RichardBuy28.47K$2.9082.57K
2024-06-01Giuffre Randall MichaelBuy28.47K$2.9082.57K
2024-01-22Lorianne Masuoka K.Buy285.00K$2.79795.15K
2024-01-22Lorianne Masuoka K.Other0——
2024-01-02Semba Charles PaulingBuy9.38K$2.8026.25K
2024-01-02Kuntz RichardBuy14.29K$2.8040.00K
2024-01-02Pilnik Richard D.Buy30.36K$2.8085.00K
2024-01-02Parsons James T.Buy21.43K$2.8060.00K
2024-01-02Giuffre Randall MichaelBuy19.20K$2.8053.75K
2023-11-16Wambeke David J.Buy20.00K$2.4649.20K
2023-06-23Von Koch ThomasBuy1.47M$3.405.00M
2023-06-23STAHLBERG JANOther0——
2023-06-23Giuffre Randall MichaelBuy65.00K$3.91254.15K
2023-06-23Giuffre Randall MichaelSell15.00K——
2023-06-23Pauls Dietrich JohnBuy12.79K$3.9150.00K
2023-06-23Semba Charles PaulingBuy12.79K$3.9150.00K
2023-06-23Kellen ScottBuy10.00K$3.9139.10K
2023-06-23Wambeke David J.Buy38.36K$3.91150.00K
2023-06-23Pilnik Richard D.Buy38.36K$3.91150.00K
2023-06-23JACINTO RICHARD IIOther0——
2023-06-01Daves Julie VanOrsdelBuy54.00K$2.73147.42K
2023-06-01Cundari Dominic RBuy27.00K$2.7373.71K
2023-06-01Gruis Kirsten LBuy67.00K$2.73182.91K
2023-06-01Kellen ScottBuy67.00K$2.73182.91K
2023-06-01Pauls Dietrich JohnBuy181.00K$2.73494.13K
2023-06-01Semba Charles PaulingBuy16.97K$2.7346.32K
2023-06-01Pilnik Richard D.Buy22.36K$2.7361.03K
2023-06-01Parsons James T.Buy16.97K$2.7346.32K
2023-06-01Lewis TanyaBuy7.49K$2.7320.46K
2023-06-01Giuffre Randall MichaelBuy16.97K$2.7346.32K
2023-05-30Kuntz RichardBuy32.32K$2.8190.82K
2023-05-30Kuntz RichardOther0——
2023-04-10Wambeke David J.Buy468.75K$1.60750.00K
2023-04-10Wambeke David J.Buy140.00K$1.57219.80K
2023-04-10Wambeke David J.Other0——
2023-03-01Lewis TanyaBuy26.44K$1.7746.80K
2023-03-01Lewis TanyaSell0——
2023-01-03Giuffre Randall MichaelBuy35.13K$1.5353.75K
2023-01-03Burroughs Amy L.Buy17.16K$1.5326.25K
2023-01-03Semba Charles PaulingBuy17.16K$1.5326.25K
2023-01-03Pilnik Richard D.Buy55.55K$1.5385.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 91, holders -11 vs prior quarter. Ownership 23.32%.

HolderSharesChangeChange %Value
COOPERMAN LEON G3.45M1.43M+70.79%24.29M
BLACKROCK, INC.2.25M396.10K+21.34%15.86M
GEODE CAPITAL MANAGEMENT, LLC894.12K113.60K+14.55%6.30M
MILLENNIUM MANAGEMENT LLC845.31K-90.28K-9.65%5.95M
STATE STREET CORP646.74K2.53K+0.39%4.55M
BLEICHROEDER LP382.32K00.00%2.69M
VANGUARD CAPITAL MANAGEMENT LLC355.52K22.07K+6.62%2.50M
OSAIC HOLDINGS, INC.338.11K18.43K+5.77%2.38M
NORTHERN TRUST CORP327.52K-11.01K-3.25%2.31M
VANGUARD PORTFOLIO MANAGEMENT LLC251.67K48.21K+23.70%1.77M
LPL FINANCIAL LLC233.50K7.45K+3.30%1.64M
VANGUARD FIDUCIARY TRUST CO207.44K19.71K+10.50%1.46M
GOLDMAN SACHS GROUP INC168.07K108.78K+183.47%1.18M
CITADEL ADVISORS LLC145.87K133.97K+1125.80%1.03M
SQUAREPOINT OPS LLC145.25K145.25KNew1.02M
BANK OF NEW YORK MELLON CORP117.82K6.74K+6.07%829.45K
MEMBERS WEALTH LLC101.38K00.00%713.73K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.96.69K96.69KNew680.71K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC96.69K8.27K+9.35%680.71K
COBALT CAPITAL MANAGEMENT, INC.90.00K90.00KNew633.60K
TREXQUANT INVESTMENT LP84.65K62.39K+280.25%595.92K
MAGNOLIA CAPITAL ADVISORS LLC77.41K00.00%544.93K
DIAMETRIC CAPITAL, LP76.62K76.62KNew539.41K
GSA CAPITAL PARTNERS LLP72.56K14.04K+24.00%511.00K
BLUE TRUST, INC.69.12K00.00%486.62K

Earnings and financials

DiaMedica Therapeutics Inc. (DMAC) trades at $9.66, with a market cap of $520.93M and a trailing P/E of -12.11. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
005000000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

DiaMedica Therapeutics (DMAC) Financials: Revenue & Earnings

DMAC$9.66+0.97 +11.16%

$520.93M

Market Cap

-12.11

P/E

—

Forward P/E

32

Score

Price History